News
In a bold move to address the growing epidemic of lifestyle diseases in India, Redial Clinic has launched a nationwide ...
Life runs on information. In living systems, that information takes two main forms: the genome and the epigenome.
Weak energy conversion from the mitochondria in our cells can disrupt insulin release, fueling the symptoms associated with ...
A major study from scientists in China is shifting how we think about aging. The long-held belief that aging is a one-way ...
GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...
Twice as many Americans now face the increased risk of death that comes from having both high blood pressure and type 2 ...
A drug commonly used to treat type 2 diabetes may also help improve a serious liver condition, according to a new clinical ...
Hosted on MSN17d
Diabetes drug metformin, GLP-1 meds might also curb asthmaDrugs already taken by millions of diabetes patients ... respiratory health. The drug has anti-inflammatory effects, they said, and it also appears to reverse some of the changes in airways ...
Pfizer halted its oral obesity drug, danuglipron, in April 2025 due to liver injury concerns, a major pipeline setback. Find ...
A global review reveals over 100 new dementia drugs which could halt or even reverse the disease are going through clinical ...
A UVa researcher has discovered that NRTIs, drugs used to treat HIV, can also help prevent Alzheimer's and a long list of ...
Glucotrack's Common Stock will continue to trade on the Nasdaq Capital Market ("Nasdaq”) under the symbol "GCTK”. The new CUSIP number for the Common Stock following the Reverse Stock Split will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results